Shopping Cart
Remove All
Your shopping cart is currently empty
RS 09 TFA
Copy Product Info
😃Good
Catalog No. T75952
Alias RS-09 TFA, RS09 TFA
RS 09 TFA is a TLR4 agonist and LPS peptide analogue that promotes NF-κB nuclear translocation and induces inflammatory cytokine secretion in RAW264.7 macrophages. It restores macrophage polarisation and inflammatory responses while disrupting the neuroprotective effects of ciliary proteins.
RS 09 TFA
Copy Product Info😃Good
Purity: 99.78%
Catalog No. T75952Alias RS-09 TFA, RS09 TFA
RS 09 TFA is a TLR4 agonist and LPS peptide analogue that promotes NF-κB nuclear translocation and induces inflammatory cytokine secretion in RAW264.7 macrophages. It restores macrophage polarisation and inflammatory responses while disrupting the neuroprotective effects of ciliary proteins.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $41 | - | In Stock | |
| 5 mg | $98 | - | In Stock | |
| 10 mg | $157 | - | In Stock | |
| 25 mg | $290 | - | In Stock | |
| 50 mg | $435 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.78%
Appearance:Solid
Color:White
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | RS 09 TFA is a TLR4 agonist and LPS peptide analogue that promotes NF-κB nuclear translocation and induces inflammatory cytokine secretion in RAW264.7 macrophages. It restores macrophage polarisation and inflammatory responses while disrupting the neuroprotective effects of ciliary proteins. |
| In vitro | In HEK-BLUETM-4 cells, RS 09 TFA (1-10 μg/mL, 24 hours) can stimulate TLR-4 and activate NF-κB[1]. In RAW264.7 cells, RS 09 TFA (5 μg/mL, 15 minutes-24 hours) binds to TLR-4 and induces NF-κB nuclear translocation as well as the secretion of inflammatory cytokines[1]. |
| In vivo | RS 09 TFA serves as an immune adjuvant, combined with the prostate cancer-specific antigen X-15 (conjugated to the carrier protein KLH) for immunization in BALB/c mice. Experimental results demonstrate that this compound can significantly elevate the concentration of X-15-specific antibodies in the mice [1]. |
| Synonyms | RS-09 TFA, RS09 TFA |
| Molecular Weight | 805.8 |
| Formula | C33H50F3N9O11 |
| Smiles | O=C([C@@H]1CCCN1C([C@@H](N)C)=O)N2CCC[C@H]2C(N[C@@H](CC3=CNC=N3)C(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(O)=O)=O)=O)=O)=O.FC(F)(C(O)=O)F |
| Storage | keep away from direct sunlight,keep away from moisture,store at low temperature | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O: ≥ 40 mg/mL, Sonication is recommended. DMSO: ≥ 80 mg/mL, Sonication is recommended. |
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (4.1 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy RS 09 TFA | purchase RS 09 TFA | RS 09 TFA cost | order RS 09 TFA | RS 09 TFA chemical structure | RS 09 TFA in vivo | RS 09 TFA in vitro | RS 09 TFA formula | RS 09 TFA molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.